BSE - Delayed Quote INR

Bliss GVS Pharma Limited (BLISSGVS.BO)

Compare
164.60
-1.10
(-0.66%)
At close: 3:47:02 PM GMT+5:30

Key Executives

Amounts are as of December 31, 2024 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in INR.
NameTitlePayExercisedYear Born
Mr. Gagan Harsh Sharma MD & Director 21.64M -- 1983
Mr. Deepak B. Sawant Chief Financial Officer -- -- 1980
Ms. Aditi Himanshu Bhatt Compliance Officer, Company Secretary & Nodal Officer -- -- --
Ms. Shruti N. Vishal Rao Executive & Whole Time Director 7.41M -- 1985
Mr. Prashant Churi Vice President of Technical Operations -- -- --
Dr. Vibha Gagan Sharma Executive & Whole Time Director 7.05M -- 1983
Mr. Sourya Das Associate Vice President -- -- --

Bliss GVS Pharma Limited

102, Hyde Park
Saki Vihar Road Andheri (East)
Mumbai, 400072
India
91 22 4216 0000 https://www.blissgvs.com
Sector: 
Healthcare
Full Time Employees: 
831

Description

Bliss GVS Pharma Limited develops, manufactures, and markets pharmaceutical formulations in India and internationally. The company offers pharma products, including capsules, creams/gels/ointments, dry powder for injections and oral suspensions, effervescent tablets, eye/ear drops, injections, liquid preparations, lozenges, nasal solutions, oral solids, parenterals, pessaries, sachets, soft gelatin capsules, suppositories, suspensions, topical preparations, and transdermal patches. It also provides other healthcare products, such as balms, nasal inhalers, over-the-counter products, petroleum jellies, roll-ons, soaps, sprays, and vaginal washes. In addition, the company offers therapeutic products consisting of analgesics, antacids, anxiolytics, and haematinics; anti-bacterials, antibiotics, anti-diabetics, anti-diarrheals, anti-emetics, antifungals, anti-haemorrhoidals, anti-helmintics, anti-infectives, anti-inflammatories, anti-malarials, anti-microbials, anti-migraines, anti-oxidants, anti-protozoals, anti-pyretics, anti-septics, anti-spasmodics, anti-ulcers, and anti-ulcerants; cough syrups and nasal decongestants; and products for erectile dysfunction, laryngitis, and pharyngitis. Further, it provides and anti-dandruff shampoos, appetizers, hand sanitizers, health and nutritional supplements, insecticides, mosquito repellants, moisturizers, prickly heat powders, skin lightening lotions, vaginal contraceptives, vaginal hygiene products, and vitamin supplements; and amino acid preparations, iron tonics, antitussives, appetite stimulants, anti-allergics, body supplements, ear wax solvents, and oral rehydration products. The company exports its products. Bliss GVS Pharma Limited was incorporated in 1984 and is based in Mumbai, India.

Corporate Governance

Bliss GVS Pharma Limited’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Upcoming Events

January 28, 2025 at 10:59 AM UTC

Bliss GVS Pharma Limited Earnings Date

Recent Events

July 19, 2024 at 12:00 AM UTC

Ex-Dividend Date

Related Tickers